Is ENTX or EVAX more undervalued in 2026?

CirclFi compares Entera Bio Ltd. (ENTX) and Evaxion A/S (EVAX) using 13 institutional-grade valuation models. ENTX has a Quality of Company score of 5.6/10 while EVAX scores 1.9/10.

Which is a better buy — ENTX or EVAX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ENTX and EVAX valuations compare?

ENTX at $1.35 and EVAX at $4.00 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ENTX vs EVAX Valuation Comparison 2026 — Intrinsic Value Analysis

ENTX

Biological Products, (No Diagnostic Substances)

Entera Bio Ltd.

Quality

5.6

out of 10

Value Trap

WARN

Price

$1.35

Last close

Models

11/13

Active

EVAX

Biological Products, (No Diagnostic Substances)

Evaxion A/S

Quality

1.9

out of 10

Value Trap

SAFE

Price

$4.00

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ENTX Fair Value	ENTX Upside	EVAX Fair Value	EVAX Upside
Bayesian DCF	Intrinsic	$0.37	-72.8%	$1.07	-73.1%
Earnings Power Value	Intrinsic	$0.16	-85.5%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.03	-97.7%	$0.18	-95.5%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ENTX vs EVAX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ENTX vs EVAX — Which Stock Is More Undervalued?

ENTX scores higher with a 5.6/10 quality rating vs EVAX's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Entera Bio Ltd. (ENTX) and Evaxion A/S (EVAX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ENTX currently trades at $1.35 with a QOC of 5.6/10, while EVAX trades at $4.00 with a QOC of 1.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).